-transparent.png){kind=logo}
Systematic simplification of the molecular structures of epicatechin gallate and epigallocatechin gallate to determine the minimum structural characteristics necessary for HIV-1 reverse transcriptase inhibition in vitro resulted in several compounds that strongly inhibited the native as well as the A17 double mutant (K103N Y181C) enzyme, which is normally insensitive to most known nonnucleoside inhibitors.
Related Publications
L M Tillekeratne, and
A Sherette, and
P Grossman, and
L Hupe, and
D Hupe, and
R A Hudson
June 2007,
Applied microbiology and biotechnology,
L M Tillekeratne, and
A Sherette, and
P Grossman, and
L Hupe, and
D Hupe, and
R A Hudson
January 2008,
Advances in pharmacology (San Diego, Calif.),
L M Tillekeratne, and
A Sherette, and
P Grossman, and
L Hupe, and
D Hupe, and
R A Hudson
January 2000,
Advances in pharmacology (San Diego, Calif.),
L M Tillekeratne, and
A Sherette, and
P Grossman, and
L Hupe, and
D Hupe, and
R A Hudson
June 2008,
Virus research,
L M Tillekeratne, and
A Sherette, and
P Grossman, and
L Hupe, and
D Hupe, and
R A Hudson
January 1992,
Journal of enzyme inhibition,
L M Tillekeratne, and
A Sherette, and
P Grossman, and
L Hupe, and
D Hupe, and
R A Hudson
March 1991,
AIDS research and human retroviruses,
L M Tillekeratne, and
A Sherette, and
P Grossman, and
L Hupe, and
D Hupe, and
R A Hudson
October 2020,
Current opinion in pharmacology,
L M Tillekeratne, and
A Sherette, and
P Grossman, and
L Hupe, and
D Hupe, and
R A Hudson
January 1996,
Biochemistry,
L M Tillekeratne, and
A Sherette, and
P Grossman, and
L Hupe, and
D Hupe, and
R A Hudson
June 2018,
Expert opinion on emerging drugs,
L M Tillekeratne, and
A Sherette, and
P Grossman, and
L Hupe, and
D Hupe, and
R A Hudson
January 2018,
The Journal of antimicrobial chemotherapy,
